CAS: 129223-22-9; Fmoc-Pro-Pro-Oh

相似化合物

15401-08-8 76932-06-4 37784-16-0

上下游产品

CAS号1366733-84-7 Fm°C-Pro-Pro-O-... | CAS号115134-39-9 N-(9-fluorenylm... | CAS号71989-31-6 Fm°C-L-脯氨酸 | CAS号2812-46-6 L-脯氨酸叔丁基酯 | CAS号20488-28-2 1-(pyrrolidine-...

Fmoc-Pro-Pro-Ome置于sodium Hydroxide体系中,用 甲醇 用作溶剂,以76%的收率获得n-芴甲氧羰基-脯氨酰-脯氨酸
参考文献:Gayathri; Gopi; Suresh Babu,Indian Journal Of Chemistry-Section B Organic And Medicinal Chemistry,1998,Vol. 37,# 2,P. 151-154
标题:Gayathri; Gopi; Suresh Babu,Indian Journal Of Chemistry-Section B Organic And Medicinal Chemistry,1998,Vol. 37,# 2,P. 151-154

专利信息

专利号:US-2020354404-A1
优先权日:2019-05-09
标 题 :Peptidomimetic agents, synthesis and uses thereof
发明人：AL-ABED YOUSEF
权利人:FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH
摘要:Compounds for use in synthesis of peptidomimetic agents; synthesis of peptidomimetic agents; peptidomimetic diagnostic and therapeutic agents; and uses of the compounds and peptidomimetic agents in drug discovery, diagnosis, prevention and treatment of diseases are described.

专利号:US-11021512-B2
优先权日:2016-10-10
标 题:Method of preparing peptides comprising a lipophilically modified lysine side chain
发明人：HENKEL BERND; PLEUSS NORBERT; HOERLEIN ROLF-LUDWIG
权利人:SANOFI SA
摘要:The present invention relates to a method of preparing a lysine side-chain modified peptide by solid phase peptide synthesis.

专利号:CN-112218876-B
优先权日:2018-04-10
标题 :Synthesis of end-capped lixisenatide

专利号:US-2011046349-A1
优先权日:2009-07-15
标题:Process for the production of exenatide and of an exenatide analogue
发明人：GIRAUD MATTHIEU; DROZ ANNE-SOPHIE; VARRAY STEPHANE; REKAI EL DJOUHAR; BRICHARD MARIE-HELENE; LATASSA DANIEL; DEVIJVER CHRISTINE; GILLES PASCAL; CAUVIN JEANNE-MARIE; ALBERICIO FERNANDO; BAS MARTA PARADIS
权利人:GIRAUD MATTHIEU; DROZ ANNE-SOPHIE; VARRAY STEPHANE; REKAI EL DJOUHAR; BRICHARD MARIE-HELENE; LATASSA DANIEL; DEVIJVER CHRISTINE; GILLES PASCAL; CAUVIN JEANNE-MARIE; ALBERICIO FERNANDO; BAS MARTA PARADIS
摘要:Exenatide, a polypeptide having the 39 amino acid sequence H-1His-Gly-Glu-Gly-5Thr-Phe-Thr-Ser-Asp-10Leu-Ser- Lys-Gln-Met-15Glu-Glu-Glu--Ala-Val-20Arg-Leu-Phe- Ile-Glu-25Trp-Leu-Lys-Asn-Gly-30Gly-Pro-Ser-Ser- Gly-35Ala--Pro-Pro-Pro-Ser-NH2, respectively its 44-mer analogue H-1His-Gly-Glu-Gly-5Thr-Phe-Thr-Ser-Asp-10Leu-Ser- Lys-Gln-Met-15Glu-Glu-Glu--Ala-Val-20Arg-Leu-Phe- Ile-Glu-25Trp-Leu-Lys-Asn-Gly-30Gly-Pro-Ser-Ser- Gly-35Ala--Pro-Pro-Ser-Lys-40Lys-Lys-Lys-Lys-Lys- NH2 is prepared via a convergent four-fragment synthesis strategy from the fragments comprising the amino acid positions 1-10, 11-21, 22-29 and 30-39, respectively 30-44.